InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (54 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
54
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Kao John e, Chairman & CEO. Director active across 2 companies, notably Alignment Healthcare, Inc.. In total, 64 filings have been recorded. Breakdown: 1 buy · 54 sells. Total volume traded: €92.2m. Activity tracked since 13 October 2021. The latest transaction was disclosed on 10 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Kao John e
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations64 total
298,000 shares@ US$13.88180.14% mcap3.9% of flowCommon StockSEC:0001628280-26-055418:0
279,644 shares@ US$19.81220.20% mcap5.4% of flowCommon StockSEC:0001628280-26-048170:0
18,356 shares@ US$20.64710.014% mcap0.4% of flowCommon StockSEC:0001628280-26-048170:1
74,936 sharesCommon StockSEC:0001628280-26-042824:0
223,064 sharesCommon StockSEC:0001628280-26-042824:1
13,801 shares@ US$21.37850.011% mcap0.4% of flowCommon StockSEC:0001628280-26-024978:1
82,299 shares@ US$20.7980.061% mcap2.0% of flowCommon StockSEC:0001628280-26-024978:2
201,900 shares@ US$20.58070.15% mcap5.0% of flowCommon StockSEC:0001628280-26-024978:0
132,241 shares@ US$20.673.1% of flowCommon StockSEC:0001628280-26-024289:0
117,759 shares@ US$21.39532.9% of flowCommon StockSEC:0001628280-26-024289:1
118,000 shares@ US$17.47832.6% of flowCommon StockSEC:0001628280-26-020614:0
73,046 shares@ US$17.841.6% of flowCommon StockSEC:0001628280-26-019910:0
338,434 shares0Common StockSEC:0001628280-26-018878:0
45,938 shares@ US$17.4760.8% of flowCommon StockSEC:0001628280-26-017810:0
180,000 shares@ US$18.18640.12% mcap4.3% of flowCommon StockSEC:0001628280-26-016617:0
180,000 shares@ US$20.48534.7% of flowCommon StockSEC:0001628280-26-007091:0
177,273 shares@ US$21.09973.8% of flowCommon StockSEC:0001628280-26-002077:0
572,437 shares@ US$18.705613.8% of flowCommon StockSEC:0001628280-25-059121:0
33,211 shares@ US$19.38180.8% of flowCommon StockSEC:0001628280-25-059121:1
180,000 shares@ US$19.01793.7% of flowCommon StockSEC:0001628280-25-056788:0
180,000 shares@ US$16.31543.3% of flowCommon StockSEC:0001628280-25-051753:0
180,000 shares@ US$17.2864.1% of flowCommon StockSEC:0001222028-25-000008:0
253,908 shares@ US$16.22934.7% of flowCommon StockSEC:0001222028-25-000007:0
180,000 shares@ US$14.59913.2% of flowCommon StockSEC:0001222028-25-000003:0
33,319 shares@ US$4.630.2% of flowCommon StockSEC:0001628280-25-034810:0
25 of 64 declarations
About Kao John e
KAO JOHN E is Président-Directeur Général. He has filed 61 filings in total, and across the 61 sampled filings the transactions span from 2021-10-15 to 2026-06-12, with a dominant transaction nature of Cession. The aggregated amounts in the sampled filings show EUR 453460 of purchases and EUR 82950561 of sales, mainly in Alignment Healthcare, Inc., where he is Chief Executive Officer.
